The Vitalograph copd-6 can help millions of undiagnosed COPD sufferers around the world

new-vitalograph-copd-6-screener

Millions of people around the world have COPD, but most of them don't know it. Undiagnosed and untreated COPD sufferers are at risk of developing advanced COPD and requiring long-term palliative care. Early diagnosis can greatly enhance the effectiveness of medical intervention, particularly if the condition is diagnosed at the pre-symptomatic stage.

The new Vitalograph copd-6 is designed to help tackle the challenge of detecting COPD by enabling primary care practitioners to 'case select' those at risk of COPD for fast, simple and effective screening.

The copd-6 identifies likely cases of COPD by measuring patients' obstructive index and FEV1/FEV6 ratio. Those whose measurements are within normal range can be screened out, allowing diagnostic spirometry resources to be focussed on those most at risk.

"The Vitalograph copd-6 is designed to help those in primary care to detect unidentified COPD. Early detection of those with COPD is a vital key to improving clinical outcomes" says Vitalograph International Sales & Marketing Manager, Bob Bemister.